Stay updated on Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page.

Latest updates to the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page
- Check2 days agoChange DetectedA new revision entry (v3.4.3) was added to the history, replacing the previous entry (v3.4.2).SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe history shows a new site revision, v3.4.2, replacing the previous v3.4.1 notice about government funding and operating status. The old funding-status notice has been removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check38 days agoChange DetectedAdded a site-wide notice about government funding and updated the revision to v3.4.1. Removed the previous revision entry v3.4.0.SummaryDifference0.5%

- Check45 days agoChange DetectedNew UI elements are added: a glossary toggle and color-coded indicators for additions and deletions in the record history. The revision label updates from v3.3.4 to v3.4.0 and a No FEAR Act Data line is now shown.SummaryDifference0.7%

- Check59 days agoChange DetectedThe Record History shows a new revision entry (v3.3.4) and a prior revision (v3.3.3) in the history log. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedVersion 3.3.3 (2025-12-19) adds Contacts/Locations and Study Status. The preceding Version 3.3.2 (2025-10-06) removes HHS Vulnerability Disclosure.SummaryDifference0.5%

Stay in the know with updates to Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page.